Meridiem Capital Partners LP Repligen Corp Transaction History
Meridiem Capital Partners LP
- $1.42 Trillion
- Q2 2025
A detailed history of Meridiem Capital Partners LP transactions in Repligen Corp stock. As of the latest transaction made, Meridiem Capital Partners LP holds 20,954 shares of RGEN stock, worth $3.12 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
20,954Holding current value
$3.12 Million% of portfolio
0.18%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
511Shares Held
59.1MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.13 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$984 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$757 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$285 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$242 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.27B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....